Nextbiomedical Publishes Landmark Study in GUT Demonstrating Nexpowder™ Significantly Reduces Rebleeding After Endoscopic Hemostasis (BioSpace)

In what could signal a paradigm shift in GI bleeding management, South Korea-based Nextbiomedical has published results in GUT showing that its novel hemostatic agent, Nexpowder™, dramatically reduces the risk of rebleeding after endoscopic intervention.